USNA

USANA Health Sciences Inc. - 10-Q Summary

Business Context and Reporting Period

This Form 10-Q covers the quarterly and six-month periods ended June 28, 2003. USANA Health Sciences, Inc. develops and manufactures nutritional, personal care, and weight management products distributed via a network marketing system of independent "Associates" and direct sales to "Preferred Customers." As of June 28, 2003, the company reported approximately 77,000 active Associates and 50,000 active Preferred Customers globally.

Key Financial Metrics

Note: The company retired all outstanding bank debt during the period. Net working capital improved to $10.9 million from $1.2 million at the end of 2002.

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 47.1% for the quarter and 45.0% for the six months compared to the prior year. Growth was driven by a 35.1% increase in active Associates, the launch of the Taiwan market (contributing $3.4M in Q2), favorable foreign currency translation ($2.3M in Q2), and price increases on key products in North America.
• Profitability: Net earnings surged 150.2% for the quarter and 177.5% for the six months. Gross margins expanded from 73.9% to 77.9% (quarterly) due to cost efficiencies, pricing strategy changes, and leverage on a rising sales base.
• Expense Ratios: Associate incentives as a percentage of sales increased slightly to 39.6% (from 38.1%) due to higher commission payouts in Australia-New Zealand and pricing strategy changes. Selling, General, and Administrative (SG&A) expenses decreased as a percentage of sales to 22.4% (from 26.7%) due to sales leverage, though absolute SG&A costs rose by $2.0 million due to new market expansion (Taiwan, Korea) and foreign currency translation.
• Debt Reduction: The company paid off all long-term debt and the line of credit, resulting in zero outstanding debt as of June 28, 2003.

Guidance, Outlook, and Risks

• Guidance: Management expects net sales of approximately $52 million for the third quarter of 2003 and $190 million for the full fiscal year 2003. This outlook is dependent on operating results in the newly opened South Korea market (opened July 14, 2003).
• Recent Developments: On July 9, 2003, USANA acquired Wasatch Product Development, Inc. (WPD) for approximately $5 million in cash to bring Sensé personal care product manufacturing in-house. The company also officially opened its South Korea market.
• Risks and Contingencies:
  • Foreign Currency: Approximately 52% of sales come from outside the U.S. A strengthening U.S. dollar negatively impacts reported sales and earnings. The company currently has no hedging instruments in place.
  • Market Expansion: Risks associated with entering new international markets (Korea, Taiwan) and reliance on the network marketing model.
  • External Factors: Potential adverse effects from the SARS outbreak (concentrated in Asia) and the war in Iraq, though management stated no material adverse effect occurred during the reported period.
  • Regulatory: Risks related to government scrutiny of network marketing practices and regulation of nutritional supplements.

Investor Verification Checklist

• Verify the sustainability of the 77.9% gross margin given the upcoming in-house manufacturing transition for the Sensé line (expected Q4 2003).
• Monitor the performance of the new South Korea market, which is a key variable in the $190M full-year sales guidance.
• Assess the impact of foreign currency fluctuations on future earnings, as the company has no hedging strategy in place.
• Review the integration and cost synergies of the Wasatch Product Development, Inc. acquisition.
• Confirm the continued growth of the active Associate base, which is the primary driver of revenue.